birth control news from FiercePharma
NewsGroup wants Ortho patch withdrawn
We've all heard the safety warnings about the Ortho-Evra birth control patch and its link to Read more...
SPOTLIGHT: Wyeth sues Watson to quash generic
It's Watson Pharmaceuticals and Wyeth in the ring, as Watson filed for FDA approval to sell a generic version of Lybrel, a birth control pill, and Wyeth responded by suing for patent infringement. Read more...
Yasmin sales spur earnings at Bayer
A 30 percent hike in earnings isn't too shabby: just ask Bayer. The company reported a rise in profits to $1.65 billion, and it expects margins of more than 20 percent for the year thanks to Read more...
| Press ReleasesPRESS RELEASE: Watson Files FDA Application for Generic YAZ(R) Watson Files FDA Application for Generic YAZ(R) - Paragraph IV Patent Challenge Underway - CORONA, Calif., Nov. 7 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical Read more... |
Get more birth control coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets